Beta-alanyl-L-Histidinato Zinc (AHZ), also known as zinc L-carnosine or polaprezinc, is a mucosal protective chelate compound of zinc and L-carnosine invented by Hamari Chemicals, Ltd. It is a quadridentate 1:1 complex of a polymeric nature. Although it contains 23% zinc and 77% L-carnosine by mass, zinc carnosine is a molecule and not a mixture of zinc and L-carnosine.

The global Beta-alanyl-L-Histidinato Zinc (AHZ) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Beta-alanyl-L-Histidinato Zinc (AHZ) Industry Forecast” looks at past sales and reviews total world Beta-alanyl-L-Histidinato Zinc (AHZ) sales in 2023, providing a comprehensive analysis by region and market sector of projected Beta-alanyl-L-Histidinato Zinc (AHZ) sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Beta-alanyl-L-Histidinato Zinc (AHZ) landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue
• Market share
• Latest developments
• M&A activity

This report also analyzes the strategies of leading global companies with a focus on Beta-alanyl-L-Histidinato Zinc (AHZ) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta-alanyl-L-Histidinato Zinc (AHZ) market.

This Insight Report evaluates key market trends, drivers, and factors shaping the global outlook for Beta-alanyl-L-Histidinato Zinc (AHZ) and breaks down the forecast by:

1. Type
2. Application
3. Geography

United States market for Beta-alanyl-L-Histidinato Zinc (AHZ) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Beta-alanyl-L-Histidinato Zinc (AHZ) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Beta-alanyl-L-Histidinato Zinc (AHZ) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Beta-alanyl-L-Histidinato Zinc (AHZ) players cover:

• Hamari Chemicals
• Suzhou Fushilai Pharmaceutical
• Jiangsu Chengxin Pharmaceutical
• Wuhan Jitai
• Wuhan BJM Pharm

This report presents a comprehensive overview, market shares, and growth opportunities of Beta-alanyl-L-Histidinato Zinc (AHZ) market by product type, application, key manufacturers, and key regions and countries.

Segmentation by Type:

• Content 98%
• Content 99%

Segmentation by Application:

• Pharmaceuticals
• Health Products

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The companies profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and market penetration:

• Hamari Chemicals
• Suzhou Fushilai Pharmaceutical
• Jiangsu Chengxin Pharmaceutical
• Wuhan Jitai
• Wuhan BJM Pharm
• Broad Well
• Jiangsu Chia Tai Fenghai Pharmaceutical
• Hunan Juidian Pharmaceutical
• Hubei Huntide Biotech

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Beta-alanyl-L-Histidinato Zinc (AHZ) market?
• What factors are driving Beta-alanyl-L-Histidinato Zinc (AHZ) market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Beta-alanyl-L-Histidinato Zinc (AHZ) market opportunities vary by end market size?
• How does Beta-alanyl-L-Histidinato Zinc (AHZ) break out by Type, by Application?